Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results
Date:8/1/2014

ght patients, subject to regulatory approval of BELVIQ by the State of Israel Ministry of Health.
  • Arena and Eisai participated at the American Diabetes Association's 74th Scientific Sessions in San Francisco, California, including giving one oral presentation, Lorcaserin Can Improve Weight Loss in Patients with Prediabetes and Reduce Progression to Diabetes in Obese and Overweight Patients, and presenting two posters, Change in A1C in Overweight Patients with Type 2 Diabetes with the Healthy Lifestyle Program Used in the Lorcaserin Phase 3 Trials and Lorcaserin Free Plasma Levels at Recommended Dose are Sufficient to Activate Serotonin 2C but not 2A or 2B Receptors.
  • An article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin entitled, "Early Weight Loss While on Lorcaserin, Diet, and Exercise as a Predictor of Week 52 Weight-Loss Outcomes," was published in the online issue of Obesity, the official peer reviewed journal of The Obesity Society.
  • BELVIQ was nominated by the Galien Foundation and Awards Committee for the 2014 Prix Galien USA Award in the Best Pharmaceutical Agent category.
  • Research & Development

  • Arena and Eisai completed enrollment of a 12-week, Phase 2, proof-of-concept trial of approximately 600 active smokers to evaluate lorcaserin as an aid to smoking cessation, and completed enrollment in a pilot study of approximately 225 patients to evaluate the safety of co-administration of lorcaserin with phentermine. Results are expected for both of these studies around the end of the year.
  • Arena initiated dosing in a Phase 1 multiple-ascending dose trial of APD334, a novel, oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P1) receptor, to evaluate the compound for the treatment of a number of autoimmune diseases.
  • Arena was granted US Patent No. 8,778,950, entitled
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
    2. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1
    3. Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena
    4. Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
    5. Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
    6. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
    7. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7
    8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
    9. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference
    10. Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
    11. Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... 19, 2014 Larry J. Merlo , President ... will speak before the National Press Club in ... recent move to stop selling tobacco products and its leadership ... health. "Dramatic changes in our health care system ... government," Merlo has said. "CVS Health has a truly unique ...
    (Date:9/19/2014)... , Sept. 19, 2014  Lpath, Inc. ... in bioactive lipid-targeted therapeutics, announced today that it ... registered shares of common stock and 3,605,042 unregistered ... purchase price for one registered share of common ... unregistered share of common stock will be $3.475.  ...
    (Date:9/19/2014)... 19, 2014  Over 200 runners participated in the ... the Radiation Oncology Institute (ROI), hosted by Radiation Business ... Park in San Francisco.  "Donations are ... of Radiation Business Solutions, "but at this point, ... $70,000 for the ROI this year. This surpasses last ...
    Breaking Medicine Technology:CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3
    ... NEW YORK, Jan. 13, 2011 Reportlinker.com announces ... in its catalogue: Teva Pharma. ... http://www.reportlinker.com/p0360241/Teva-Pharma-Industries-Ltd-PharmaVitae-Profile.html Introduction ... performance for Teva in the prescription pharmaceutical sector. ...
    ... 13, 2011 Reportlinker.com announces that a new market ... UCB S.A.: PharmaVitae Profile ... This analysis examines the historical and forecast performance ... encompasses global company strategy, portfolio and pipeline analysis and ...
    Cached Medicine Technology:Reportlinker Adds Teva Pharma. Industries Ltd: PharmaVitae Profile 2Reportlinker Adds UCB S.A.: PharmaVitae Profile 2
    (Date:9/19/2014)... 2014 Are you tired of having ... with seasonal allergies or sinus congestion? Fortunately, an inventor ... , She conceived of Nose Pal to avoid ... nose in public. Since it prevents nasal drip and ... conditions, particularly when cooking or working closely with others. ...
    (Date:9/19/2014)... (HealthDay News) -- As kids transition from elementary to ... according to a recent study. But the ... found that verbal and physical bullying declines as students ... and prevention strategies must address all types of bullying ... girls, the researchers said. The study was published recently ...
    (Date:9/19/2014)... Phoenix, AZ (PRWEB) September 19, 2014 Hastings ... over 30 years in the industry, announces a record number ... firm handles a wide variety of serious injury cases as ... cases along with dog bite related accident cases and others. ... Hastings and Hastings has stood the test of time when ...
    (Date:9/19/2014)... According to a report from HarrisMartin ... Xarelto, named as defendants in several lawsuits filed in ... the court to dismiss those suits because the alleged ... with Philadelphia.* The cases include, for instance, Fontan v. ... Comm. Pls., Philadelphia Cty.), which was brought by a ...
    (Date:9/19/2014)... 2014 (HealthDay News) -- Your brain structure could help predict ... study suggests. Researchers at Yale University found those with ... the parietal cortex may be more likely to engage in ... , , The study, funded by the U.S. National Institute ... women living in the Northeast. The researchers sought to determine ...
    Breaking Medicine News(10 mins):Health News:Nasal Drip Eliminator Invented by InventHelp Client (LCC-218) 2Health News: Cyberbullying Seems to Ramp Up in Middle School 2Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 3Health News:Brain Structure Might Help Predict Risky Behavior 2
    ... Wants Consumers to Go Back to the Basics: Healthy Living ... Chance to Win a Luxury Resort & Spa ExperienceWESTCHESTER, Ill., ... people who make New Year,s resolutions fall off the wagon ... we give ourselves such lofty expectations in the first place? ...
    ... NEW YORK, March 5 HMS Holdings Corp. ... for government healthcare programs, today announced the promotions ... Christina Dragonetti to Executive Vice President, Commercial Markets; ... Markets. These promotions follow the company,s announcement on ...
    ... AED industry-leading commitment to research and developmentGrand opening ... the American Academy of Dermatology (AAD)HAYWARD, Calif., March ... SLTM ) today announced the opening of the ... new product development, facilitate research on the innovative ...
    ... AAD Launches include New Technologies, Innovative Applications and New ... several new launches at the upcoming 67th annual meeting ... CA. Aligned with the company,s strategic imperative to stay ... launches will focus on the company reinforcing its ...
    ... they,re better able to play sports, be accepted by ... to glasses, contact lenses improve how children feel about ... acceptance among friends, a study of 484 nearsighted children ... spectacle wear on self-perception and the perception of others, ...
    ... Broadcasts of The Patient Channel and The Newborn ... Wegener Corporation (Nasdaq: WGNR ), a ... data distribution networks worldwide, today announced that the ... division of the iVillage Networks, recently upgraded its ...
    Cached Medicine News:Health News:Samantha Harris Launches 'A Toast for Everyday Health' 2Health News:Samantha Harris Launches 'A Toast for Everyday Health' 3Health News:Samantha Harris Launches 'A Toast for Everyday Health' 4Health News:HMS Holdings Corp. Announces Executive Promotions 2Health News:Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center 2Health News:Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center 3Health News:Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting 2Health News:Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting 3Health News:Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting 4Health News:Contact Lenses Boost Kids' Self-Image 2Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 2Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 3Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 4Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 5
    Singe-pull lace design provides easy-on application to provide support and immobilization of the wrist while preserving finger mobility...
    ManuTrain is an active wrist support that has optional features for increased stabilization....
    ... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
    ... 3-Point® Polycentric Hinged Ulnar Deviation Splint uses ... the hand with ulnar deviation at the ... grasp or pinch. Radial and ulnar polycentric ... unimpeded flexion and extension. Padded, malleable finger ...
    Medicine Products: